GlassScriptPhysician profile
Susan Davis Wherley
NPI 1740716117
$3,970.24
in general payments reported to CMS, 2019-2025
10 companies · $209 in 2025
The $209 reported for 2025 was more than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $353 · 2021: $448 · 2022: $968 · 2023: $1,103 · 2024: $889 · 2025: $209.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,202.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,201.50 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $1,502.49 | 2019-2025 | Advantage System, Upsylon, Solyx Sis System |
| Axonics, INC. | $701.40 | 2022-2024 | Axonics |
| Caldera Medical, INC | $469.92 | 2021-2024 | Desara |
| Medtronic, INC. | $416.38 | 2021-2023 | Interstim, Ligasure |
| Coloplast Corp | $295.19 | 2022-2024 | |
| Bluewind Medical | $233.35 | 2024-2025 | Revi |
| Abbvie INC. | $110.12 | 2019 | |
| Coopersurgical, INC. | $108.75 | 2022-2023 | Summit Doppler |
| Teleflex LLC | $107.64 | 2024 | Solesta |
| Femselect INC. | $25.00 | 2024 | Enplace |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Susan Wherley listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.